GSK Remains Positive On Medicare Rx, Outcome Of AWP Suit
Executive Summary
GlaxoSmithKline continues to see only an upside from the potential creation of a Medicare prescription drug benefit, Pharmaceutical Operations President David Stout told investors in New York City Feb. 13